Parkinson's Disease Market Set to Experience Unprecedented Growth During the Forecast Period (2023-32) - Estimates DelveInsight | Biogen, Denali Therapeutics, AbbVie, Annovis Bio, Amneal Pharma, Roche, BioVie, Cerevance, Clene Nanomedicine

The Parkinson's Disease Market size in the 7MM was approximately USD 3,226 million in 2022, and it is projected to increase during the forecast period. As per DelveInsight, the Parkinson's Disease Market is anticipated to evolve immensely in the coming years owing to the rise in the number of cases and the launch of new therapies in the market.

DelveInsight's "Parkinson's Disease Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Parkinson's Disease Market Size and Share in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).

The market report covers emerging drugs, treatment practices, market share of individual Parkinson's Disease therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current Parkinson's Disease treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.

Parkinson's Disease: An Overview
Parkinson's disease is a progressive disorder that is caused by the degeneration of nerve cells in the part of the brain called the substantia nigra, which controls movement. The cause of Parkinson's disease remains unknown, but it has long been hypothesized that exposure to environmental risk factors may be one cause, along with an inherited susceptibility. The majority of cases are thought to arise sporadically, although up to 20% of people with Parkinson's disease also have a first-degree relative with Parkinson's disease.

Classic presenting features of Parkinson's disease include motor symptoms, such as bradykinesia, rigidity, rest tremor, and postural instability. However, non-motor symptoms, such as depression, cognitive impairment, pain, and autonomic disturbances, are also often present, and they can severely affect a patient's quality of life.

As per a global study of the Global Burden of Diseases (GBD) 2016 Parkinson's disease, collaborators to estimate the Parkinson's Disease prevalence. Among neurological disorders examined in the Global Burden of Disease, Injuries, and Risk Factors Study (GBD), in 2015, Parkinson's Disease was the fastest-growing in prevalence, disability, and deaths.

Parkinson's Disease Market Key Facts
• The Parkinson's disease market size in the 7MM will increase at a CAGR of 11.2% due to the increase in diagnosed prevalent cases of the disease and the anticipated launch of emerging Parkinson's disease therapies.
• Among EU4 and the UK, Germany accounts for the maximum Parkinson's disease market size in 2022 while the United Kingdom occupies the bottom of the ladder in 2022.
• According to DelveInsight estimates, the US accounted for approximately 1.1 million diagnosed cases whereas in the EU4 and the UK, there were around 1.2 million diagnosed Parkinson's disease cases in 2022.
• Among the EU4 and the UK, Germany had the highest diagnosed prevalent population of Parkinson's disease (approximately 0.5 million cases), followed by France (approximately 0.2 million cases) in 2022. On the other hand, Italy had the lowest diagnosed prevalent population in EU4 and the UK countries and the 7MM.
• Japan accounted for 0.2 million diagnosed cases of Parkinson's disease in 2022.
• Parkinson's disease has been identified as a male-dominant disease; in our analysis, the number of males suffering was higher as compared to females. In 2022, 54% of cases of Parkinson's disease were in males, while 46% of cases were in females in the 7MM.

Discover How Parkinson's Disease Market Will Grow by 2032:
https://www.delveinsight.com/report-store/parkinsons-disease-market-size-analysis-treatment?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Parkinson's Disease Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted market size by analyzing the impact of current and emerging Parkinson's Disease therapies in the market. It also provides a detailed assessment of the Parkinson's Disease market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the market trend for each marketed Parkinson's Disease drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MOA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Parkinson's Disease Epidemiology
The epidemiology section covers detailed insights into the historical, and current Parkinson's Disease patient pool and forecasted epidemiology trends for every seven major countries (7MM) from 2019 to 2032.

The Report Covers the Parkinson's Disease Epidemiology Segmented as -
• Diagnosed Prevalent Population of Parkinson's Disease in the 7MM (2019-32)
• Gender-specific Diagnosed Prevalent Population of Parkinson's Disease in the 7MM (2019-32)
• Age-specific Diagnosed Prevalent Population of Parkinson's Disease in the 7MM (2019-32)
• Stage-specific Diagnosed Prevalent Population of Parkinson's Disease in the 7MM (2019-32)

Get Key Insights Into the Evolving Parkinson's Disease Epidemiology Trends @
https://www.delveinsight.com/report-store/parkinsons-disease-market-size-analysis-treatment?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Parkinson's Disease Drugs Uptake and Pipeline Development Activities
The drugs' uptake section focuses on the rate of uptake of the potential drugs recently launched in the Parkinson's Disease market or expected to be launched during the study period. The analysis covers the market share by Parkinson's Disease drugs, patient uptake by therapies, and sales of each drug.

The report's drugs uptake section helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs. It allows the comparison of the drugs based on market share and size, which again will be helpful in investigating factors important in understanding the market dynamics and in making financial and regulatory decisions.

The report also covers the Parkinson's Disease Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Explore More About Ongoing Pipeline Development Activities @
https://www.delveinsight.com/sample-request/parkinsons-disease-market-size-analysis-treatment?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Parkinson's Disease Therapeutics Assessment
Several major pharma and biotech companies are developing therapies for Parkinson's disease. Currently, Cerevel Therapeutics is leading the therapeutics market with its Parkinson's disease drug candidates in the most advanced stage of clinical development.

Leading Companies in the Parkinson's Disease Therapeutics Market Include
Cerevel Therapeutics, Inhibikase Therapeutics, Neuraly, Peptron, Biogen, Roche, Brain Neurotherapy Bio, Inc., Modag, Annovis Bio Inc., BioVie Inc., United Neuroscience Ltd., Luye Pharma Group, AbbVie, UCB Biopharma SRL, InnoMedica Schweiz AG, Integrative Research Laboratories, H. Lundbeck A/S, Shanghai WD Pharmaceutical Co., Ltd., Cerevance Beta, Inc., Nobilis Therapeutics Inc., BlueRock Therapeutics, Taiwan Mitochondrion Applied Technology Co., Ltd., NeuroDerm Ltd., Pharma Two B, Serina Therapeutics, Sun Pharma Advanced Research Company Limited, CuraSen Therapeutics, Inc., Takeda, Xoc Pharmaceuticals, Sumitomo Pharma Co., Ltd., XWPharma, Athira Pharma, Aptinyx, VistaGen Therapeutics, Inc., 1ST Biotherapeutics, Inc., Novo Nordisk A/S, AstraZeneca, MedImmune, Anavex Life Sciences Corp., Living Cell Technologies, Intra-Cellular Therapies, Inc., Alkahest, Inc., Kissei Pharmaceutical Co., Ltd., and many others.

Emerging and Marketed Parkinson's Disease Therapies Covered in the Report Include
Several major companies are developing novel therapies for the treatment of Parkinson's Disease. Some of the key therapies in the pipeline include Tavapadon (Cerevel Therapeutics), P2B001 (Pharma Two B Ltd), BIIB122 (Biogen/ Denali Therapeutics), ABBV-951 (AbbVie), Buntanetap (Annovis Bio), IPX203 (Amneal Pharmaceuticals), RO7046015 (Hoffmann-La Roche), NE3107 (BioVie), CVN424 (Cerevance), CNM-Au8 (Clene Nanomedicine) and ITI-214 (Intra-Cellular Therapies, among others.

Learn More About the Emerging Therapies & Key Companies in the Parkinson's Disease Therapeutics Market:
https://www.delveinsight.com/sample-request/parkinsons-disease-market-size-analysis-treatment?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Parkinson's Disease Competitive Intelligence Analysis
4. Parkinson's Disease Market Overview at a Glance
5. Parkinson's Disease Background and Overview
6. Parkinson's Disease Patient Journey
7. Parkinson's Disease Epidemiology and Patient Population
8. Parkinson's Disease Treatment Algorithm, Current Treatment, and Medical Practices
9. Parkinson's Disease Unmet Needs
10. Key Endpoints of Parkinson's Disease Treatment
11. Parkinson's Disease Marketed Products
12. Parkinson's Disease Emerging Therapies
13. Parkinson's Disease Seven Major Market Analysis
14. Attribute Analysis
15. Parkinson's Disease Market Outlook (7 major markets)
16. Parkinson's Disease Access and Reimbursement Overview
17. KOL Views on the Parkinson's Disease Market.
18. Parkinson's Disease Market Drivers
19. Parkinson's Disease Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.

Download the Sample PDF to Get Detailed Insights About the Report's Offerings @
https://www.delveinsight.com/sample-request/parkinsons-disease-market-size-analysis-treatment?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

-------------------------------------------- xx --------------------------------------------
Other Trending Healthcare Reports by DelveInsight
Pulmonology Devices Market
https://www.delveinsight.com/report-store/pulmonology-devices-market

Small Cell Lung Cancer Market
https://www.delveinsight.com/report-store/small-cell-lung-cancer-market

Bronchiectasis Market
https://www.delveinsight.com/report-store/bronchiectasis-market

Lennox Gastaut Syndrome Market
https://www.delveinsight.com/report-store/lennox-gastaut-syndrome-market

Holter Monitor Market
https://www.delveinsight.com/report-store/holter-monitor-market

Muscle Invasive Bladder cancer Market
https://www.delveinsight.com/report-store/muscle-invasive-bladder-cancer-market

Osteochondrodysplasia Market
https://www.delveinsight.com/report-store/osteochondrodysplasia-market

Anesthesia Machines Market
https://www.delveinsight.com/report-store/anesthesia-workstation-machines-market

Secondary Myelofibrosis Market
https://www.delveinsight.com/report-store/secondary-myelofibrosis-market

Guillain-Barre Syndrome (GBS) Market
https://www.delveinsight.com/report-store/guillain-barre-syndrome-gbs-market

Hepatitis A Market
https://www.delveinsight.com/report-store/hepatitis-a-market

Sickle Cell Disease Market
https://www.delveinsight.com/report-store/sickle-cell-disease-market

Mucinous Cystic Neoplasms (MCNs) Market
https://www.delveinsight.com/report-store/mucinous-cystic-neoplasms-mcns-market

Overt Hepatic Encephalopathy Market
https://www.delveinsight.com/report-store/overt-hepatic-encephalopathy-market

Familial Hypercholesterolemia Market
https://www.delveinsight.com/report-store/familial-hypercholesterolemia-market-report

Lateral Epicondylitis (Tennis Elbow) Disease Market
https://www.delveinsight.com/report-store/lateral-epicondylitis-tennis-elbow-disease-market

Diverticulitis Market
https://www.delveinsight.com/report-store/diverticulitis-market

Crows Feet Market
https://www.delveinsight.com/report-store/crows-feet-market

Helicobacter Pylori Infections Market
https://www.delveinsight.com/report-store/helicobacter-pylori-infections-market

Charcot-Marie-Tooth Disease Market
https://www.delveinsight.com/report-store/charcot-marie-tooth-disease-market

Neurovascular Thrombectomy Devices Market
https://www.delveinsight.com/report-store/neurovascular-thrombectomy-devices-market

Neurothrombectomy Devices Market
https://www.delveinsight.com/report-store/neurovascular-thrombectomy-devices-market

Stargardt Disease (STGD) Market
https://www.delveinsight.com/report-store/stargardt-disease-stgd-market

Venous Leg Ulcer Market
https://www.delveinsight.com/report-store/venous-leg-ulcer-market

Genital Herpes Market
https://www.delveinsight.com/report-store/genital-herpes-market-forecast

Idiopathic Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/idiopathic-thrombocytopenic-purpura-market

Morquio Syndrome Market
https://www.delveinsight.com/report-store/morquio-syndrome-market

Lymphoedema Market
https://www.delveinsight.com/report-store/lymphoedema-market

Neurotrophic Keratopathy Market
https://www.delveinsight.com/report-store/neurotrophic-keratopathy-market

Oncolytic Virus Cancer Therapy Market
https://www.delveinsight.com/report-store/oncolytic-virus-cancer-therapy-market

Orthostatic Hypotension Market
https://www.delveinsight.com/report-store/orthostatic-hypotension-market

Advanced Wound Care (AWC) Market
https://www.delveinsight.com/report-store/advanced-wound-care-market

Opioid-related Disorders Market
https://www.delveinsight.com/report-store/opioid-related-disorders-market

Ankylosing Spondylitis (AS) Market
https://www.delveinsight.com/report-store/ankylosing-spondylitis-as-market

Chronic Insomnia Market
https://www.delveinsight.com/report-store/chronic-insomnia-market

Microscopic Polyangiitis (MPA) Market
https://www.delveinsight.com/report-store/microscopic-polyangiitis-mpa-market

Esophageal Squamous Carcinoma Market
https://www.delveinsight.com/report-store/esophageal-squamous-carcinoma-market

Hypertrophic Scar Market
https://www.delveinsight.com/report-store/hypertrophic-scar-market

Chemotherapy Induced Neutropenia (CIN) Market
https://www.delveinsight.com/report-store/chemotherapy-induced-neutropenia-cin-market

Idiopathic Interstitial Pneumonia Market
https://www.delveinsight.com/report-store/idiopathic-interstitial-pneumonia-market

Diphtheria Market
https://www.delveinsight.com/report-store/diphtheria-market

Dyslipidemia Market
https://www.delveinsight.com/report-store/dyslipidemia-market

Thymus Cancer Market
https://www.delveinsight.com/report-store/thymus-cancer-market

Tendonitis Market
https://www.delveinsight.com/report-store/tendonitis-market

Alpha-Antitrypsin Deficiency Market
https://www.delveinsight.com/report-store/alpha-antitrypsin-deficiency-market

Factor XA Inhibitor Market
https://www.delveinsight.com/report-store/factor-xa-inhibitor-market

Undifferentiated Pleomorphic Sarcoma Market
https://www.delveinsight.com/report-store/undifferentiated-pleomorphic-sarcoma-market

Carcinoid Tumor Syndrome Market
https://www.delveinsight.com/report-store/carcinoid-tumor-syndrome-market

Primary Progressive Multiple Sclerosis (PPMS) Market
https://www.delveinsight.com/report-store/primary-progressive-multiple-sclerosis-ppms-market

Thalassemia Market
https://www.delveinsight.com/report-store/thalassemia-market

Contact Info:
Shruti Thakur
Manager (Marketing & Branding)
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.